|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
AU2004204463B2
(en)
|
2003-01-10 |
2009-02-12 |
Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services National Institutes Of Health |
Catalytic domains of beta(1,4)-galactosyltransferase I having altered donor and acceptor specificities, domains that promote in vitro protein folding, and methods for their use
|
|
US8759490B2
(en)
|
2005-03-24 |
2014-06-24 |
Millennium Pharamaceuticals, Inc. |
Antibodies that bind OV064 and methods of use therefor
|
|
EP1868647A4
(en)
|
2005-03-24 |
2009-04-01 |
Millennium Pharm Inc |
OV064 BINDING ANTIBODIES AND METHOD FOR THEIR USE
|
|
KR101704734B1
(ko)
|
2005-07-01 |
2017-02-09 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
US8609816B2
(en)
*
|
2005-12-08 |
2013-12-17 |
Medarex, L.L.C. |
Human monoclonal antibodies to O8E
|
|
US9121853B2
(en)
|
2006-03-20 |
2015-09-01 |
Mayo Foundation For Medical Education And Research |
B7-H4 expression on tumor vasculature
|
|
EP2586458B1
(en)
|
2006-12-27 |
2016-08-24 |
The Johns Hopkins University |
Compositions and methods for treating inflammation and auto-immune diseases
|
|
AR069747A1
(es)
|
2007-11-30 |
2010-02-17 |
Medarex Inc |
Conjugado anticuerpo monoclonal anti-b7h4- farmaco y metodos de utilizacion
|
|
WO2009102820A2
(en)
|
2008-02-11 |
2009-08-20 |
Government Of The U.S A., As Represented By The Secretary, Department Of Health And Human Services |
Modified sugar substrates and methods of use
|
|
US8852599B2
(en)
|
2011-05-26 |
2014-10-07 |
Bristol-Myers Squibb Company |
Immunoconjugates, compositions for making them, and methods of making and use
|
|
EP2717916B1
(en)
|
2011-06-10 |
2017-03-08 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
US9676854B2
(en)
|
2011-08-15 |
2017-06-13 |
Medimmune, Llc |
Anti-B7-H4 antibodies and their uses
|
|
GB201115841D0
(en)
|
2011-09-13 |
2011-10-26 |
Genovis Ab |
Protein and method
|
|
US9422351B2
(en)
|
2011-11-03 |
2016-08-23 |
The Trustees Of The University Of Pennsylvania |
Isolated B7-H4 specific compositions and methods of use thereof
|
|
AU2013361275B2
(en)
|
2012-12-19 |
2016-11-24 |
Amplimmune, Inc. |
Anti-human B7-H4 antibodies and their uses
|
|
MX2015010777A
(es)
|
2013-03-14 |
2016-04-25 |
Genentech Inc |
Anticuerpos e inmunoconjugados anti-b7-h4.
|
|
US9562099B2
(en)
|
2013-03-14 |
2017-02-07 |
Genentech, Inc. |
Anti-B7-H4 antibodies and immunoconjugates
|
|
WO2015054659A1
(en)
|
2013-10-11 |
2015-04-16 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
TW201625689A
(zh)
|
2014-09-12 |
2016-07-16 |
建南德克公司 |
抗-b7-h4抗體及免疫結合物
|
|
US10626176B2
(en)
|
2014-10-31 |
2020-04-21 |
Jounce Therapeutics, Inc. |
Methods of treating conditions with antibodies that bind B7-H4
|
|
CN107810273B
(zh)
*
|
2015-04-23 |
2022-09-27 |
西纳福克斯股份有限公司 |
用为或衍生自β-(1,4)-N-乙酰半乳糖胺转移酶的糖基转移酶修饰糖蛋白的方法
|
|
EP3414328B1
(en)
|
2016-02-08 |
2024-01-10 |
Synaffix B.V. |
Enzymes for trimming of glycoproteins
|
|
WO2018021301A1
(ja)
|
2016-07-26 |
2018-02-01 |
静岡県 |
抗b7-h4抗体
|
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
|
WO2018195302A1
(en)
|
2017-04-19 |
2018-10-25 |
Bluefin Biomedicine, Inc. |
Anti-vtcn1 antibodies and antibody drug conjugates
|
|
US10814011B1
(en)
|
2017-06-16 |
2020-10-27 |
Nantbio, Inc. |
Anti-B7-H4 antibodies and methods
|
|
SG11202000387YA
(en)
|
2017-08-25 |
2020-03-30 |
Five Prime Therapeutics Inc |
B7-h4 antibodies and methods of use thereof
|
|
CN112566934B
(zh)
|
2018-01-23 |
2024-09-17 |
奈斯科尔公司 |
B7-h4抗体及其使用方法
|
|
BR112020015736A2
(pt)
|
2018-02-11 |
2020-12-08 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Anticorpo anti-b7-h4, fragmento de ligação a antígeno do mesmo e uso farmacêutico do mesmo
|
|
WO2019165077A1
(en)
|
2018-02-21 |
2019-08-29 |
Five Prime Therapeutics, Inc. |
B7-h4 antibody formulations
|
|
AU2019226009B2
(en)
|
2018-02-21 |
2025-11-20 |
Five Prime Therapeutics, Inc. |
B7-H4 antibody dosing regimens
|
|
CN108948204B
(zh)
|
2018-06-15 |
2023-01-13 |
苏州旭光科星抗体生物科技有限公司 |
抗人b7-h4单克隆抗体、鉴定方法、应用和试剂盒
|
|
AU2019361923B2
(en)
|
2018-10-15 |
2026-07-09 |
Five Prime Therapeutics, Inc. |
Combination therapy for cancer
|
|
CA3117050A1
(en)
|
2018-10-29 |
2020-05-07 |
Mersana Therapeutics, Inc. |
Cysteine engineered antibody-drug conjugates with peptide-containing linkers
|
|
AU2020288275A1
(en)
|
2019-06-06 |
2022-02-03 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Anti-B7-H4 antibody–drug conjugate and medicinal use thereof
|
|
BR112022013255A2
(pt)
|
2020-01-09 |
2022-09-06 |
Mersana Therapeutics Inc |
Conjugados anticorpo-fármaco específicos de sítio com ligantes contendo peptídeo
|
|
US20230112085A1
(en)
|
2020-01-30 |
2023-04-13 |
Apeximmune Therapeutics Inc. |
Anti-b7-h4 constructs and uses thereof
|
|
KR20220154757A
(ko)
|
2020-03-18 |
2022-11-22 |
젠맵 에이/에스 |
B7h4에 결합하는 항체
|
|
CN116196435B
(zh)
|
2020-04-02 |
2025-12-02 |
梅尔莎纳医疗公司 |
包含sting激动剂的抗体药物缀合物
|
|
JP7726534B2
(ja)
|
2020-06-30 |
2025-08-20 |
諾納生物(蘇州)有限公司 |
抗b7h4抗体及びその二重特異性抗体および用途
|
|
WO2022147532A1
(en)
|
2021-01-04 |
2022-07-07 |
Mersana Therapeutics, Inc. |
B7h4-targeted antibody-drug conjugates and methods of use thereof
|